https://www.chinalawandpractice.com/China Law & Practice NewsALM: Media, Intelligence and Events - working together to empower our audiences and partners to discover, connect and compete. http://www.chinalawandpractice.com/2026/09/24/in-the-news-concurrent-civil-and-criminal-proceedings-search-engine-ai-liability-and-blackrock-china-unit-secures-qdii-license/In the News: Concurrent Civil and Criminal Proceedings; Search Engine AI Liability; and BlackRock China Unit Secures QDII Licensehttps://feeds.feedblitz.com/~/969722579/0/chinalawandpractice/news/~In-the-News-Concurrent-Civil-and-Criminal-Proceedings-Search-Engine-AI-Liability-and-BlackRock-China-Unit-Secures-QDII-License/http://www.chinalawandpractice.com/2026/09/24/in-the-news-concurrent-civil-and-criminal-proceedings-search-engine-ai-liability-and-blackrock-china-unit-secures-qdii-license/Thu, 24 Sep 2026 00:01:27 EST      ]]> https://images.chinalawandpractice.com/contrib/content/uploads/sites/294/2024/09/Justice-Scales-Article-202409130429.jpg Civil proceedings permitted to run concurrently with criminal proceedings under new regulations | Chinese court finds search engine AI's software did not infringe on copyright | BlackRock expands access to China's outbound investment market

      
]]> http://www.chinalawandpractice.com/2026/09/22/in-house-insights-navigating-cross-border-capital-markets/In-House Insights: Navigating Cross-Border Capital Marketshttps://feeds.feedblitz.com/~/969461372/0/chinalawandpractice/news/~InHouse-Insights-Navigating-CrossBorder-Capital-Markets/http://www.chinalawandpractice.com/2026/09/22/in-house-insights-navigating-cross-border-capital-markets/Tue, 22 Sep 2026 02:45:45 EST      ]]> https://k2-prod-alm.s3.us-east-1.amazonaws.com/brightspot/db/5a/ddd264784253b67a65d0eeb2694f/amanda-lau-img-6753.PNG Amanda Lau, senior lead counsel for Citi's investment banking business in Asia discusses managing shifting global geopolitical dynamics, navigating A-to-H listing complexities, and the strategic balance of Hong Kong's listing reforms.

      
]]> http://www.chinalawandpractice.com/2026/09/18/in-the-news-typical-anti-monopoly-cases-china-pe-fund-freeze-and-record-offshore-rmb-borrowing/In the News: Typical Anti-Monopoly Cases; China PE Fund Freeze; and Record Offshore RMB Borrowinghttps://feeds.feedblitz.com/~/969255782/0/chinalawandpractice/news/~In-the-News-Typical-AntiMonopoly-Cases-China-PE-Fund-Freeze-and-Record-Offshore-RMB-Borrowing/http://www.chinalawandpractice.com/2026/09/18/in-the-news-typical-anti-monopoly-cases-china-pe-fund-freeze-and-record-offshore-rmb-borrowing/Fri, 18 Sep 2026 05:36:39 EST      ]]> https://k2-prod-alm.s3.us-east-1.amazonaws.com/brightspot/93/cd/f746f5d24f00a98f7c532722483c/antitrust.jpeg Chinese court rules that short-term price fluctuations are generally not unfair | China approved zero new PE fund registration in June | Offshore renminbi borrowing hits record high amid China's record-low interest rates

      
]]> http://www.chinalawandpractice.com/2026/09/14/legislation-roundup-ai-disputes-private-investment-and-ai-customer-services/Legislation Roundup: AI Disputes, Private Investment, and AI Customer Serviceshttps://feeds.feedblitz.com/~/969085028/0/chinalawandpractice/news/~Legislation-Roundup-AI-Disputes-Private-Investment-and-AI-Customer-Services/http://www.chinalawandpractice.com/2026/09/14/legislation-roundup-ai-disputes-private-investment-and-ai-customer-services/Mon, 14 Sep 2026 06:21:56 EST      ]]> SPC clarifies patent protection in invention/creation using AI | Stringent eligibility requirements are set forth for individual PE investors | National standards are issued for live and intelligent customer services

      
]]> http://www.chinalawandpractice.com/2026/09/14/national-financial-regulatory-administration-measures-for-the-administration-of-the-engagement-in-trust-business-in-the-real-estate-sector-by-trust-companies-trial-implementation/National Financial Regulatory Administration, Measures for the Administration of the Engagement in Trust Business in the Real Estate Sector by Trust Companies (Trial Implementation)https://feeds.feedblitz.com/~/969085031/0/chinalawandpractice/news/~National-Financial-Regulatory-Administration-Measures-for-the-Administration-of-the-Engagement-in-Trust-Business-in-the-Real-Estate-Sector-by-Trust-Companies/http://www.chinalawandpractice.com/2026/09/14/national-financial-regulatory-administration-measures-for-the-administration-of-the-engagement-in-trust-business-in-the-real-estate-sector-by-trust-companies-trial-implementation/Mon, 14 Sep 2026 06:13:31 EST      ]]> NFRA sets forth the criteria for trust companies engaging in real estate trusts / CLP Reference: 4110/26.08.28 ; Promulgated: 2026-08-28 ; Effective: 2027-03-01

      
]]> http://www.chinalawandpractice.com/2026/09/14/provisions-for-simplified-measures-for-the-protection-of-personal-information-by-small-scale-personal-information-handlers/Provisions for Simplified Measures for the Protection of Personal Information by Small-Scale Personal Information Handlershttps://feeds.feedblitz.com/~/969084641/0/chinalawandpractice/news/~Provisions-for-Simplified-Measures-for-the-Protection-of-Personal-Information-by-SmallScale-Personal-Information-Handlers/http://www.chinalawandpractice.com/2026/09/14/provisions-for-simplified-measures-for-the-protection-of-personal-information-by-small-scale-personal-information-handlers/Mon, 14 Sep 2026 06:09:15 EST      ]]> Transfers of personal information of less than 100,000 persons may enjoy simplified procedures / CLP Reference: 5600/26.07.22 ; Promulgated: 2026-07-22 ; Effective: 2026-09-01

      
]]> http://www.chinalawandpractice.com/2026/09/14/challenges-facing-chinese-biotech-deals/Challenges Facing Chinese Biotech Dealshttps://feeds.feedblitz.com/~/969080495/0/chinalawandpractice/news/~Challenges-Facing-Chinese-Biotech-Deals/http://www.chinalawandpractice.com/2026/09/14/challenges-facing-chinese-biotech-deals/Mon, 14 Sep 2026 03:21:03 EST      ]]> https://k2-prod-alm.s3.us-east-1.amazonaws.com/brightspot/ba/63/8de25bd2454e862cfee5243aa472/healthcare.jpeg Can Chinese biotech deals continue amid increasingly stringent U.S. and Chinese restrictions?

      
]]>